Peter Lawson Stock Analyst Profile - Barclays Research Coverage - Stocknear

Peter Lawson

Stock Analyst at Barclays

(3.7)
# 2434
Out of 5,506 analysts
146
Total ratings
Success rate
Average return

45 Stocks

Name Action PT Current % Upside Ratings Updated
ONC BeOne Medicines
Initiates Coverage On: Overweight
385
343.87 11.96% 1 Sep 18, 2025
IDYA IDEAYA Biosciences
Initiates Coverage On: Overweight
40
27.64 44.72% 1 Sep 4, 2025
SDGR Schrodinger
Initiates Coverage On: Overweight
25
20.59 21.42% 1 Aug 14, 2025
REPL Replimune Group
Downgrades: Equal-Weight
17 3
4.73 -36.58% 4 Jul 23, 2025
EXEL Exelixis
Maintains: Equal-Weight
29 40
40.09 -0.22% 6 Jul 10, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
8 3
1.78 68.54% 9 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
10 2
1.21 65.29% 4 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
1 1
n/a n/a 3 May 14, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 10
6.38 56.74% 3 May 13, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
5 4
2.34 70.94% 7 May 12, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
22 6
11.77 -49.02% 2 May 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 11
9.57 14.94% 1 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 16
9.61 66.49% 8 May 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
40 15
8.37 79.21% 2 May 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
63 47
n/a n/a 4 Apr 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
29 14
13.36 4.79% 7 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 3
2.15 39.53% 5 Apr 2, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 3
2.11 42.18% 2 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
9 4
1.35 196.3% 1 Feb 27, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
54 60
46.71 28.45% 3 Sep 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
14 17
5.48 210.22% 5 Sep 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
32 33
15.6 111.54% 4 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
5
n/a n/a 4 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
92 66
34.21 92.93% 2 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
75 105
n/a n/a 10 Jul 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
20 31
9.38 230.49% 2 Jul 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
18 13
7.76 67.53% 1 May 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
9 26
n/a n/a 6 Apr 30, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
27 31
n/a n/a 6 Dec 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
1.47 240.14% 4 Aug 4, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
175 50
n/a n/a 2 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
7 4
3.3 6.06% 4 Jul 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
355 365
102.12 257.42% 1 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Overweight
46
40.5 13.58% 2 Oct 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
40
n/a n/a 1 May 5, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
450
60.55 643.19% 1 Mar 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
33
n/a n/a 1 Mar 4, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
65 75
n/a n/a 2 Dec 4, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
49
n/a n/a 1 May 31, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
21
n/a n/a 1 Apr 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
19 5
n/a n/a 4 Apr 9, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
16 45
67.74 -33.57% 2 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
17 45
3.92 1047.96% 2 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Jan 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
70
n/a n/a 1 Jul 14, 2017